Kelly Lawrence W & Associates’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Kelly Lawrence W & Associates's EXAS Position: Q1 2026 in Review
Kelly Lawrence W & Associates sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 200 shares — an estimated $20.3K sold.
Kelly Lawrence W & Associates first reported a position in EXAS in Q1 2020 and held it in 24 quarters. The position peaked at $109K in Q2 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Kelly Lawrence W & Associates reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Kelly Lawrence W & Associates sold 200 Exact Sciences shares in Q1 2026, an estimated $20.3K.
- Kelly Lawrence W & Associates first reported a position in Exact Sciences in Q1 2020 and held it in 24 quarters.
- Kelly Lawrence W & Associates's Exact Sciences position peaked at $109K in Q2 2023.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Kelly Lawrence W & Associates's 13F filing for Q1 2026, filed 15 May 2026.